Page last updated: 2024-08-23

alovudine and Bone Cancer

alovudine has been researched along with Bone Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K1
Benz, MR; Buck, AK; Herrmann, K; Pomykala, KL; Wieder, HA1
Boerman, OC; Fleuren, ED; Flucke, UE; Franssen, GM; Houghton, PJ; Oyen, WJ; Roeffen, MH; van der Graaf, WT; Versleijen-Jonkers, YM1
Benz, MR; Czernin, J; Eilber, FC; Federman, N; Tap, WD; Tchekmedyian, N1
Berriolo-Riedinger, A; Brunotte, F; Cochet, A; Couturier, O; Girault, S; Rousseau, C1

Reviews

2 review(s) available for alovudine and Bone Cancer

ArticleYear
PET tracers in musculoskeletal disease beyond FDG.
    Seminars in musculoskeletal radiology, 2014, Volume: 18, Issue:2

    Topics: Amino Acids; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Choline; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Musculoskeletal Diseases; Neoplasms; Positron-Emission Tomography

2014
Utilization of positron emission tomography in the management of patients with sarcoma.
    Current opinion in oncology, 2009, Volume: 21, Issue:4

    Topics: Bone Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma

2009

Other Studies

3 other study(ies) available for alovudine and Bone Cancer

ArticleYear
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:12

    Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers

2013
Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models.
    International journal of cancer, 2014, Dec-15, Volume: 135, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Positron-Emission Tomography; Protein Kinase Inhibitors; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2014
Bone metastasis of a breast cancer detected by 3'-deoxy-3'-18F-fluorothymidine PET/CT.
    Nuklearmedizin. Nuclear medicine, 2009, Volume: 48, Issue:5

    Topics: Adult; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Dideoxynucleosides; Docetaxel; Epirubicin; Female; Humans; Positron-Emission Tomography; Taxoids; Tomography, X-Ray Computed; Treatment Outcome

2009